Fast Market Research

New Report Available: Atopic Dermatitis - Pipeline Review, H2 2014

Fast Market Research recommends "Atopic Dermatitis - Pipeline Review, H2 2014" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 09/26/2014 -- Global Markets Direct's, 'Atopic Dermatitis - Pipeline Review, H2 2014', provides an overview of the Atopic Dermatitis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Atopic Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atopic Dermatitis and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

View Full Report Details and Table of Contents

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides a snapshot of the global therapeutic landscape of Atopic Dermatitis

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Atopic Dermatitis and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Atopic Dermatitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Atopic Dermatitis pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

Reasons to Get This Report:

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Atopic Dermatitis

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Atopic Dermatitis pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies Mentioned in this Report: Bristol-Myers Squibb Company, Johnson & Johnson, Kyowa Hakko Kirin Co., Ltd., Valeant Pharmaceuticals International, Inc., Daiichi Sankyo Company, Limited, Merck & Co., Inc., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Amorepacific Corporation, Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., LEO Pharma A/S, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Celgene Corporation, Bayer AG, AlbireoPharma, NicOx S.A., Nuvo Research Inc., Yungjin Pharm Ind. Co., Ltd., Regeneron Pharmaceuticals, Inc., HanAll Biopharma Co., Ltd., AnGes MG, Inc., Provectus Biopharmaceuticals, Inc., R-Tech Ueno, Ltd., Paloma Pharmaceuticals, Inc., Upsher-Smith Laboratories, Inc., Foamix Ltd., Anacor Pharmaceuticals, Inc., AnaptysBio, Inc., IMMD Inc., Circassia Holdings Ltd., Oxagen Limited, Melior Discovery, Inc., Grupo Ferrer Internacional, S.A., Xencor, Inc., Welichem Biotech Inc., ChemoCentryx, Inc., Vitae Pharmaceuticals, Inc., arGEN-X BV, SWITCH Biotech LLC, Promius Pharma, LLC, Celsus Therapeutics Plc, Pharis Biotec GmbH, Vicore Pharma AB, Otsuka Holdings Co., Ltd., LegoChem Biosciences, Inc, Fountain Biopharma Inc., Pergamum AB, VivaCell Biotechnology Espana S.L., Brickell Biotech, Inc., NeoPharm Co., Ltd., Herantis Pharma plc., Creabilis SA, Polyrizon Ltd., sterna biologicals Gmbh & Co KG, Dermira Inc., Istituto Italiano di Tecnologia, Thesan Pharmaceuticals, Inc., ChironWells GmbH, Pharmedartis GmbH

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 800-844-8156

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Atopic Dermatitis - Pipeline Review, H1 2014
- Myelodysplastic Syndrome - Pipeline Review, H2 2014
- Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014
- Metastatic Colorectal Cancer - Pipeline Review, H2 2014
- Malaria - Pipeline Review, H2 2014
- Chronic Pain - Pipeline Review, H2 2014
- Small-Cell Lung Cancer - Pipeline Review, H2 2014
- Bladder Cancer - Pipeline Review, H2 2014
- Myocardial Infarction - Pipeline Review, H2 2014
- Systemic Lupus Erythematosus - Pipeline Review, H2 2014